GAO Releases Report on States’ Regulation of PBMs
Drug Topics
APRIL 19, 2024
Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.
Fri.Apr 19, 2024
233 
Gap in Medicaid Impacts Access to Services for Justice-Involved Patients
Pharmacy Times
APRIL 19, 2024
Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Swipe Right on Wellness: The Rise of Digital Therapeutics in Mental Health
Drug Topics
APRIL 19, 2024
Digital therapeutics are positioned as front-runners in the increasingly digital future of health care.
STAT+: New antibiotics were underprescribed for hard-to-treat infections, study finds
STAT
APRIL 19, 2024
Although U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year period, hospital doctors instead gave older, generic remedies to more than 40% of patients battling those stubborn pathogens, according to a new analysis. Moreover, 80% of the time these older antibiotics were already known to be highly toxic or ineffective, according to the analysis.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Medicare-Focused Insurance Agency Could Benefit Independent Pharmacies
Drug Topics
APRIL 19, 2024
A Q&A with Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee.
Online chatter points to broad layoffs at Optum—but the full extent is unclear
Fierce Healthcare
APRIL 19, 2024
UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear. | UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC
Pharmacy Times
APRIL 19, 2024
In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate.
Enhancing Patient-Pharmacist Relationships Through Conversation
Drug Topics
APRIL 19, 2024
Listening carefully to determine what’s beneath the surface of a patient’s concerns can make a world of difference in providing quality care.
Opinion: Moving the conversation about obesity beyond the scale
STAT
APRIL 19, 2024
Every so often, the conversations that people in health care have become so pervasive that they dominate the zeitgeist, intersecting with mainstream media and popular culture. Oprah Winfrey’s recent ABC special “Shame, Blame, and the Weight Loss Revolution” is a good example of this. Now streaming on Hulu, the broadcast garnered widespread attention, including coverage from People Magazine and The New York Times.
Study: Chemotherapy to Treat Breast Cancer Increases Risk of Lung Cancer
Pharmacy Times
APRIL 19, 2024
Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer
STAT
APRIL 19, 2024
WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday. The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.
FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC
Pharmacy Times
APRIL 19, 2024
With this approval, alectinib is the first anaplastic lymphoma kinase inhibitor to be approved for patients with ALK-positive, early-stage non-small cell lung cancer.
Pennsylvania providers file suit against Aetna over breach of contract
Fierce Healthcare
APRIL 19, 2024
A Pennsylvania provider group has filed suit against Aetna this week, alleging the insurer conducted multiple breaches of contract. | A Pennsylvania provider group has filed suit against Aetna this week, alleging the insurer conducted multiple breaches of contract.
Reuters Pharma USA 2024 – Serena Goodwin
pharmaphorum
APRIL 19, 2024
Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Roche snags postsurgery FDA nod for Alecensa, eyes even broader lung cancer use
Fierce Pharma
APRIL 19, 2024
Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. | Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. The Swiss pharma has now secured an FDA approval in the post-surgical setting as it continues to test the drug in additional patient populations.
Avive pockets $57M for portable defibrillator to speed up cardiac arrest response
Fierce Healthcare
APRIL 19, 2024
Portable defibrillator company Avive Solutions raised $56.5 million in growth equity financing to build out its staff and commercial developments. | The company, which launched in 2017, has contracts with four cities for its network of AEDs to improve survival rates of sudden cardiac arrest. It has raised tens of millions to expand operations.
STAT+: Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more
STAT
APRIL 19, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape. However, we do foresee several naps in our future, if only to recover from promenading with the official mascots. We also hope to catch up on our reading and hold another listening party with Mrs.
LogiPharma Europe 2024: Niklas Adamsson Discusses Ways to Improve Visibility and Risk Management for Cold Chain Shipping
Pharmaceutical Commerce
APRIL 19, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Environtainer, suggests how to improve visibility and risk management for cold chain shipping.
STAT+: Up and down the ladder: The latest comings and goings
STAT
APRIL 19, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease
Pharmacy Times
APRIL 19, 2024
The primary endpoint of the study was clinical remission at week 52 with vedolizumab
AI Guided Care Plans Streamline Workflow and Improve Patient Care
Drug Topics
APRIL 19, 2024
When AI is incorporated into pharmacy workflows, the technology can help pharmacists demonstrate the value of their profession.
AskBio’s AB-1002 gene therapy receives FDA fast-track status
Pharmaceutical Technology
APRIL 19, 2024
The US Food and Drug Administration (FDA) has granted fast-track designation to Bayer subsidiary Asklepios BioPharmaceutical’s (AskBio) investigational gene therapy AB-1002, aimed at treating congestive heart failure (CHF).
Behind the ‘encouraging’ new results for Amylyx’s beleaguered drug
PharmaVoice
APRIL 19, 2024
Where Amylyx ultimately failed in ALS, it could prevail in a rare disease. The doctor leading this research explains why.
FDA clears Roche’s Alecensa for adjuvant use in NSCLC
pharmaphorum
APRIL 19, 2024
Roche's Alecenesa has become the first ALK inhibitor to be approved by the FDA for adjuvant use in early-stage, ALK+ NSCLC
'The Top Line': Winning formulas for the best biotech and drug names
Fierce Pharma
APRIL 19, 2024
This week on “The Top Line,” we're joined by Fierce Biotech Senior Editor Annalee Armstrong and Fierce Pharma Marketing Senior Editor Ben Adams. | This week on "The Top Line," we are joined by Annalee Armstrong, Senior Editor at Fierce Biotech, and Ben Adams, Senior Editor of Fierce Pharma Marketing, to discuss Fierce's take on March Madness.
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
pharmaphorum
APRIL 19, 2024
Cerevel's first phase 3 trial of Parkinson's drug tavapadon is positive - good news for AbbVie which is trying to buy the biotech for $8.
Chutes & Ladders—Sutter Health appoints first CMO; More change at Banner Health
Fierce Healthcare
APRIL 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry.
Hyundai Bio plans trials of antiviral for dengue fever
pharmaphorum
APRIL 19, 2024
Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever
Vox Pop Pharma - companies keen to find alternatives to animal testing - read their views
Outsourcing Pharma
APRIL 19, 2024
Earlier this week, Charles River Laboratories International, Inc. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.
Microbial burden assessment of solid pharmaceutical products
European Pharmaceutical Review
APRIL 19, 2024
The “accurate, precise, and robust” data obtained via the dew point chilled mirror method, means it is an “outstanding” approach for quantifying water activity status in tablets and capsules, according to a paper published in RPS Pharmacy and Pharmacology Reports. It has value for direct assessment to determine microbiological bioburden , stated Prada-Ramírez et al.
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
Drug Topics
APRIL 19, 2024
This approval is the second biosimilar approval for manufacturer Alvotech.
Experimental AI predicts whether cancer drugs will work
pharmaphorum
APRIL 19, 2024
Researchers in the US have developed an artificial intelligence tool that can predict how a patient will respond to cancer treatment
FibroGen settles with former employees who it claimed stole trade secrets
Fierce Pharma
APRIL 19, 2024
Nearly a year and a half after FibroGen slapped a pair of former employees with a lawsuit alleging trade secrets theft, both the plaintiffs and the defendants are walking away from the case little | Nearly a year and a half after FibroGen slapped a pair of former employees with a lawsuit alleging trade secrets theft, both the plaintiffs and the defendants are walking away from the case little worse for wear.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Drug Topics
APRIL 19, 2024
Check out important updates from the FDA for the week of April 15.
Let's personalize your content